Literature DB >> 10725752

Activation of the IL-4 STAT pathway in rheumatoid synovium.

U Müller-Ladner1, M Judex, W Ballhorn, F Kullmann, O Distler, K Schlottmann, R E Gay, J Schölmerich, S Gay.   

Abstract

STATs act as second messenger after binding of a signaling molecule to its receptor. IL-4 STAT is directly involved in the IL-4-dependent gene transcription in the nucleus. We examined the expression and activation of IL-4 STAT and its related kinase Jak-1 in rheumatoid synovium. Rheumatoid arthritis (RA) synovial frozen sections of patients with short-term (<1 year) and long-term disease (>2 years) were examined using in situ hybridization and immunohistochemistry. IL-4 STAT mRNA could be detected in synovium of patients with short-term and long-term RA. The most intensive expression of IL-4 STAT mRNA could be seen in follicular inflammatory infiltrates. In the synovial lining, both fibroblasts and macrophages expressed IL-4 STAT mRNA. IL-4 STAT and Jak-1 protein was expressed by synoviocytes, and up-regulation could be induced after stimulation with IL-4. Activation of IL-4 STAT was reflected by phosphorylation of IL-4 STAT. The results indicate that IL-4 STAT is involved in key pathomechanisms in RA synovium and that IL-4 STAT-dependent pathways operate in early and late stages of the disease and presumably contribute to inhibitory immune mechanisms in RA synovium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725752     DOI: 10.4049/jimmunol.164.7.3894

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis.

Authors:  J G Walker; M J Ahern; M Coleman; H Weedon; V Papangelis; D Beroukas; P J Roberts-Thomson; M D Smith
Journal:  Ann Rheum Dis       Date:  2005-08-11       Impact factor: 19.103

2.  Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis.

Authors:  T Shouda; T Yoshida; T Hanada; T Wakioka; M Oishi; K Miyoshi; S Komiya; K Kosai; Y Hanakawa; K Hashimoto; K Nagata; A Yoshimura
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 3.  IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity.

Authors:  Hongmei Li; Abdolmohamad Rostami
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

4.  Neuronal IL-4Rα modulates neuronal apoptosis and cell viability during the acute phases of cerebral ischemia.

Authors:  Han Kyu Lee; Sehwon Koh; Donald C Lo; Douglas A Marchuk
Journal:  FEBS J       Date:  2018-05-24       Impact factor: 5.542

5.  Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis.

Authors:  R Goldbach-Mansky; S Suson; R Wesley; C E Hack; H S El-Gabalawy; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-10-07       Impact factor: 19.103

6.  Interleukin-18 is regulated by G protein pathways and protein kinase signals in human fibroblasts.

Authors:  Marc K Schuler; Wilhelm K Aicher
Journal:  Rheumatol Int       Date:  2003-07-15       Impact factor: 2.631

7.  Interleukin-4 suppresses IL-1-induced expression of matrix metalloproteinase-3 in human gingival fibroblasts.

Authors:  Kosunique Jenkins; Masoud Javadi; Ruth Carter Borghaei
Journal:  J Periodontol       Date:  2004-02       Impact factor: 6.993

8.  Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1).

Authors:  Marion Hückel; Uta Schurigt; Andreas H Wagner; Renate Stöckigt; Peter K Petrow; Klaus Thoss; Mieczyslaw Gajda; Steffen Henzgen; Markus Hecker; Rolf Bräuer
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Multiparameter phospho-flow analysis of lymphocytes in early rheumatoid arthritis: implications for diagnosis and monitoring drug therapy.

Authors:  Carole L Galligan; Janet C Siebert; Katherine A Siminovitch; Edward C Keystone; Vivian Bykerk; Omar D Perez; Eleanor N Fish
Journal:  PLoS One       Date:  2009-08-20       Impact factor: 3.240

10.  STAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid Arthritis.

Authors:  Krista Kuuliala; Antti Kuuliala; Riitta Koivuniemi; Hannu Kautiainen; Heikki Repo; Marjatta Leirisalo-Repo
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.